Patent

1. A compound of formula (I)

wherein:

X 1 , X 2 , X 3 and X 4 represent, independently of each other, a hydrogen or halogen atom, a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -fluoroalkoxy, cyano, C(O)NR 1 R 2 , nitro, NR 1 R 2 , C 1 -C 6 -thioalkyl, —S(O)—C 1 -C 6 -alkyl, —S(O) 2 —C 1 -C 6 -alkyl, SO 2 NR 1 R 2 , NR 3 COR 4 , NR 3 SO 2 R 5 or aryl group, the aryl being optionally substituted with one or more substituents chosen from a halogen and a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -fluoroalkoxy, nitro or cyano group;

W represents a fused bicyclic group of formula:

bonded to the nitrogen atom via positions 1, 2, 3 or 4; wherein

A represents a 5- to 7-membered heterocycle comprising from one to three heteroatoms chosen from O, S and N;

the carbon atom(s) of A being optionally substituted with one or more groups chosen from a hydrogen atom, a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, aryl, aryl-C 1 -C 6 -alkylene, oxo or thio group;

the nitrogen atom(s) of A being optionally substituted with R 6 when the nitrogen is adjacent to a carbon atom substituted with an oxo group, or with R 7 in the other cases;

n is equal to 1, 2 or 3;

Y represents a heteroaryl optionally substituted with one or more groups chosen from a halogen atom and a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, hydroxyl, C 1 -C 6 -alkoxy, C 1 -C 6 -fluoroalkoxy, cyano, C(O)NR 1 R 2 , nitro, NR 1 R 2 , C 1 -C 6 -thioalkyl, SH, —S(O)—C 1 -C 6 -alkyl, —S(O) 2 —C 1 -C 6 -alkyl, SO 2 NR 1 R 2 , NR 3 COR 4 , NR 3 SO 2 R 5 , aryl-C 1 -C 6 -alkylene or aryl group, the aryl and the aryl-C 1 -C 6 -alkylene being optionally substituted with one or more substituents chosen from a halogen and a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -fluoroalkoxy, nitro or cyano group;

R 1 and R 2 represent, independently of each other, a hydrogen atom or a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, aryl-C 1 -C 6 -alkylene or aryl group; or R 1 and R 2 together form, with the nitrogen atom that bears them, an azetidinyl, pyrrolidinyl, piperidyl, azepinyl, morpholinyl, thiomorpholinyl, piperazinyl or homopiperazinyl group, this group being optionally substituted with a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, aryl-C 1 -C 6 -alkylene or aryl group;

R 3 and R 4 represent, independently of each other, a hydrogen atom or a C 1 -C 6 -alkyl, aryl-C 1 -C 6 -alkylene or aryl group;

R 5 represents a C 1 -C 6 -alkyl, aryl-C 1 -C 6 -alkylene or aryl group;

R 6 represents a hydrogen atom or a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, aryl-C 1 -C 6 -alkylene or aryl group;

R 7 represents a hydrogen atom or a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, aryl-C 1 -C 6 -alkylene, C 1 -C 6 -alkyl-C(O)—, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene-(CO)—, C 1 -C 6 -fluoroalkyl-C(O)—, C 3 -C 7 -cycloalkyl-C(O)—, aryl-C(O)—, aryl-C 1 -C 6 -alkylene-C(O)—, C 1 -C 6 -alkyl-S(O) 2 —, C 1 -C 6 -fluoroalkyl-S(O) 2 —, C 3 -C 7 -cycloalkyl-S(O) 2 —, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene-S(O) 2 —, aryl-S(O) 2 —, aryl-C 1 -C 6 -alkylene-S(O) 2 — or aryl group;

the sulfur atom(s) of the heterocycle A or of the heteroaryl Y optionally being in oxidized form;

the nitrogen atom(s) of the heterocycle A or of the heteroaryl Y optionally being in oxidized form;

or an acid-addition salt thereof.

2. The compound of formula (I) according to claim 1 , wherein X 1 , X 2 , X 3 , X 4 represent, independently of each other, a hydrogen or halogen atom, a C 1 -C 6 -alkyl, C 1 -C 6 -fluoroalkyl group or a group NR 1 R 2 , and wherein R 1 and R 2 being as defined in claim 1 ;

or an acid-addition salt thereof.

3. The compound of formula (I) according to claim 1 , wherein

W represents a fused bicyclic group of formula:

bonded to the nitrogen atom via positions 1, 2, 3 or 4;

and W is chosen from indolinyl, isoindolyl, isoindolinyl, benzofuryl, dihydrobenzofuryl, benzothiophenyl, dihydrobenzothiophenyl, benzoxazolyl, dihydrobenzoxazolinyl, isobenzofuryl, dihydroisobenzofuryl, benzimidazolyl, dihydrobenzimidazolyl, indolyl, indazolyl, benzothiazolyl, isobenzothiazolyl, dihydroisobenzothiazolyl, benzotriazolyl, quinolyl, dihydroquinolyl, tetrahydroquinolyl, isoquinolyl, dihydroisoquinolyl, tetrahydroisoquinolyl, benzoxazinyl, dihydrobenzoxazinyl, benzothiazinyl, dihydrobenzothiazinyl, cinnolinyl, quinazolinyl, dihydroquinazolinyl, tetrahydroquinazolinyl, quinoxalinyl, dihydroquinoxalinyl, tetrahydroquinoxalinyl, phthalazinyl, dihydrophthalazinyl, tetrahydrophthalazinyl, tetrahydrobenz[b]azepinyl, tetrahydrobenz[c]azepinyl, tetrahydrobenz[d]azepinyl, tetrahydrobenzo[b][1,4]diazepinyl, tetrahydrobenzo[e][1,4]diazepinyl, tetrahydrobenzo[b][1,4]oxazepinyl or tetrahydrobenzo[b][1,4]thiazepinyl groups; and wherein

the carbon or nitrogen atom(s) of the said group W being optionally substituted one or more times with substituents as defined in claim 1 ;

or an acid-addition salt thereof.

4. The compound of formula (I) according to claim 1 , wherein

W represents a fused bicyclic group of formula:

bonded to the nitrogen atom via positions 2 or 3;

and W is chosen from benzimidazolyl, indolyl, benzothiazolyl, quinolyl, tetrahydroquinolyl and benzoxazinyl groups; and wherein

the carbon atom(s) of A being optionally substituted with one or more groups selected from C 1 -C 6 -alkyl, C 1 -C 6 -fluoroalkyl, C 3 -C 7 -cycloalkyl or oxo group; and

the nitrogen atom(s) of A being optionally substituted with R 6 when the nitrogen is adjacent to a carbon atom substituted with an oxo group, R 6 representing a hydrogen atom or a C 1 -C 6 -alkyl group; or with R 7 in the other cases, wherein R 7 representing a C 1 -C 6 -alkyl group or a C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene group;

or an acid-addition salt thereof.

5. The compound of formula (I) according to claim 1 , wherein n is equal to 1 or 2;

or an acid-addition salt thereof.

6. The compound of formula (I) according to claim 1 , wherein

Y represents a heteroaryl chosen from pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, imidazolyl, benzimidazolyl, benzothiazolyl, thiazolyl, furyl, quinolyl, isoquinolyl, quinoxalinyl groups, the heteroaryl being optionally substituted with one or more groups chosen from C 1 -C 6 -alkyl, C 1 -C 6 -fluoroalkyl, aryl-C 1 -C 6 -alkylene or NR 1 R 2 groups; and wherein R 1 and R 2 together forming, with the nitrogen atom that bears them, a morpholinyl group;

or an acid-addition salt thereof.

7. The compound of formula (I) according to claim 1 , wherein

X 1 , X 2 , X 3 , X 4 represent, independently of each other, a hydrogen or halogen atom, a C 1 -C 6 -alkyl, C 1 -C 6 -fluoroalkyl or NR 1 R 2 group, wherein R 1 and R 2 being as defined in claim 1 :

W represents a fused bicyclic group of formula:

bonded to the nitrogen atom via positions 2 or 3; and W is chosen from benzimidazolyl, indolyl, benzothiazolyl, quinolyl, tetrahydroquinolyl or benzoxazinyl groups; and wherein

the carbon atom(s) of A being optionally substituted with one or more C 1 -C 6 -alkyl, C 1 -C 6 -fluoroalkyl, C 3 -C 7 -cycloalkyl or oxo groups; and

the nitrogen atom(s) of A being optionally substituted with R 6 when the nitrogen is adjacent to a carbon atom substituted with an oxo group, R 6 representing a hydrogen atom or a C 1 -C 6 -alkyl group; or with R 7 in the other cases, R 7 representing a C 1 -C 6 -alkyl group or a C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene group;

n is equal to 1 or 2; and

Y represents a heteroaryl chosen from pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, imidazolyl, benzimidazolyl, benzothiazolyl, thiazolyl, furyl, quinolyl, isoquinolyl, quinoxalinyl groups, the heteroaryl being optionally substituted with one or more groups chosen from C 1 -C 6 -alkyl, C 1 -C 6 -fluoroalkyl, aryl-C 1 -C 6 -alkylene and NR 1 R 2 groups; wherein R 1 and R 2 together forming, with the nitrogen atom that bears them, a morpholinyl group;

or an acid-addition salt thereof.

8. A process for preparing a compound of formula (I) according to claim 1 , comprising:

reacting a compound of formula (IV)

wherein X 1 , X 2 , X 3 , X 4 , Y and n are as defined in claim 1 and B represents a C 1 -C 6 -alkoxy group,

with an amide of the compound of formula (V)

wherein W is as defined in claim 1 ,

in a refluxing solvent, the amide of the compound of formula (V) being prepared via the prior action of trimethylaluminum on the amine of formula (V).

9. A pharmaceutical composition comprising a compound of formula (I) according to claim 1 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

10. A pharmaceutical composition comprising a compound of formula (I) according to claim 2 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

11. A pharmaceutical composition comprising a compound of formula (I) according to claim 3 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

12. A pharmaceutical composition comprising a compound of formula (I) according to claim 4 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

13. A pharmaceutical composition comprising a compound of formula (I) according to claim 5 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

14. A pharmaceutical composition comprising a compound of formula (I) according to claim 6 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

15. A pharmaceutical composition comprising a compound of formula (I) according to claim 7 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.